STAT

APRIL 5, 2024

If it is true that spring has sprung — and we are still awaiting definitive evidence — you might want to enjoy the great outdoors and watch the trees and flowers slowly come to life. The rotation will likely include this , this , this , this and this. And what about you? Continue to STAT+ to read the full story…

Vaccines 112

Vaccines Immunization 112

pharmaphorum

AUGUST 23, 2022

With COVID-19 vaccines and therapeutics developed in rapid time, Ben Hargreaves investigates why this has not been the case with the creation of a treatment for Long COVID. Once the scale of the threat was understood, the pharmaceutical industry reacted with a rapidity and agility that allowed vaccines to be developed at a record rate.

Vaccines 134

Vaccines Immunization FDA 134

PharmaShots

MARCH 14, 2023

Rare diseases have distinct definitions across geography. The act includes drugs, vaccines, and therapeutics that are intended to treat a disease affecting <200,000 American citizens. While accrediting the term rare to a particular disease, the prevalence of the disease is examined first.

FDA 40

FDA Immunization Compounding Vaccines 40

The FDA Law Blog

JUNE 2, 2023

Most are new or revised definitions and administrative changes, but several proposals represent new policies that should be of concern to drug manufacturers. What is noteworthy about this proposed definition is that it adds a new requirement that “[a] manufacturer must make data available to CMS to support its finding.”

Labelling 59

Labelling Vaccines FDA Immunization 59

Pharmaceutical Technology

DECEMBER 1, 2022

Liminatus Pharma has entered a definitive business combination agreement with special purpose acquisition company (SPAC) Iris Acquisition to create a business with a pro forma enterprise value of nearly $334m. The GCC Vaccine is being analysed in Phase II clinical trials.

Immunization 52

Immunization Vaccines Communication 52

pharmaphorum

AUGUST 16, 2022

Following the success of LNP-mRNA vaccines, we have seen an influx of novel types of lipids based nanocarriers over the last 12 months, progress has been made to minimize immuno-toxicity challenges – from maximizing therapeutic window to fine-tuning the immune response. .

Immunization 52

Immunization Vaccines 52

Pharmafile

DECEMBER 12, 2023

AstraZeneca has announced that it has entered into a definitive agreement to acquire Icosavax for approximately $15 per share or an approximate total value of $1.1bn.

Immunization 59

Immunization Vaccines 59

pharmaphorum

SEPTEMBER 8, 2021

The UK should think twice before backing widespread use of COVID-19 booster vaccinations, as to do so could place unnecessary burden on the NHS over the winter, according to AstraZeneca chief executive Pascal Soriot. It has already said that at-risk people, such as those with weakened immune systems, will be in line for a third dose.

Vaccines 83

Vaccines Immunization Hospitals 83

Pharmaceutical Technology

MAY 24, 2023

CohBar has entered into a definitive merger deal with Morphogenesis to advance a late-stage clinical immuno-oncology pipeline of therapies to overcome resistance to cancer immunotherapy. Morphogenesis’s technologies include Immune Fx (IFx) personalised cancer vaccines and tumour microenvironment (TME) modulators.

Vaccines 52

Vaccines Immunization 52

pharmaphorum

JANUARY 5, 2023

have announced they have entered into a definitive agreement for Moderna to acquire OriCiro at a cost of $85 million. Most recently, of course, Moderna developed one of the earliest vaccines against the COVID-19 pandemic to be authorised and approved. Biotech Moderna, Inc. and OriCiro Genomics K.K.

Vaccines 97

Vaccines Immunization 97

Pharmaceutical Technology

MARCH 2, 2023

Merck overview Merck is a biopharmaceutical company focused on the discovery, development, manufacturing and marketing of prescription medicines, biologic therapies, vaccines and animal health products. The company provides animal health products such as vaccines, poultry products, livestock products and aquaculture products.

Chemotherapy 40

Chemotherapy FDA Vaccines Immunization 40

The Infectious Pharmacist

AUGUST 19, 2021

Anyway, today’s “Booster Doses – Part 1” will go over some of the basics of booster doses and review the use of additional doses (not boosters) in patients with compromised immune systems. At the bottom of each part in this series you will find a link to some background posts that may be helpful, as well as a list of definitions.

Immunization 52

Immunization Vaccines Hospitals FDA 52

The Infectious Pharmacist

AUGUST 20, 2021

In Booster Doses – Part 1 I wrote about some of the basics of booster doses and the need for “additional” doses (not booster doses) in patients with compromised immune systems. Today I’m going to talk about some of the rationale behind booster doses in patients with healthy immune systems. The vaccines are still highly effective.

Vaccines 52

Vaccines Immunization Nursing Homes Hospitals 52

The Infectious Pharmacist

AUGUST 21, 2021

Pfizer vs. Moderna and a note on vaccine dosing and timing. You probably have read news reports about a preprint article stating that the Moderna vaccine appeared more effective than the Pfizer vaccine, at least several months after vaccination. Should I stick with the same mRNA vaccine I got for the first two doses?

Vaccines 52

Vaccines Immunization Adverse Reactions Hospitals 52

The Checkup by Singlecare

DECEMBER 5, 2022

If you receive an unexpected charge in the mail—long after having received treatment—it’s most definitely an unpleasant surprise. The CDC recommends an influenza vaccine to everyone older than six months—unless they have a health condition that prevents them from getting it. There are benefits to getting immunized even in December.

Vaccines 98

Vaccines Labelling Immunization FDA 98

Pharmaceutical Technology

AUGUST 26, 2008

We are now one of the ten largest biopharma companies in the world with a rich armoury of new technology, comprising a full suite of technologies, small molecules, antibodies and vaccines to create new human medicines.” Biotechnology’s place in the pharmaceutical industry is assured, that much is clear.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Vaccines Immunization 40

pharmaphorum

JULY 30, 2021

In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health literacy has never been more important. Again, vaccine hesitancy is probably the most obvious example here.

Vaccines 119

Vaccines Pharmaceutical Companies Pharmaceutical Companies Communication 119

European Pharmaceutical Review

OCTOBER 3, 2024

Vidofludimus calcium (IMU-838), a drug developed by Immunic Therapeutics, is a prime example of this. Although effective, this approach often results in significant side effects, including increased susceptibility to viral reactivation, infections, and, in some cases, a heightened risk of cancer due to reduced immune surveillance.

Immunization 52

Immunization Patient Care Vaccines 52

The Checkup by Singlecare

FEBRUARY 16, 2023

Risk factors for developing colitis symptoms include if you are white, of Jewish ethnicity, increasing age, undergoing abdominal radiation treatment, taking antibiotics, consuming contaminated water or food, or have food allergies, sickle cell anemia, a family member with inflammatory bowel disease, or a weakened immune system.

Immunization 52

Immunization Vaccines 52

The Infectious Pharmacist

APRIL 6, 2021

Pfizer sent out a press release on March 31 with results from a small study of their mRNA vaccine in patients 12 through 15 years of age. The study enrolled about 2,200 patients with half getting the mRNA vaccine and half getting placebo. What about the Moderna vaccine? What about the vaccines in kids younger than 12 years old?

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies Communication 52

The Checkup by Singlecare

FEBRUARY 6, 2023

Risk factors of pneumonia are age older than 65, chronic obstructive pulmonary disorder ( COPD ), HIV infection , weakened immune system and smoking. The early signs of pneumonia vary based on the cause, but they are all due to the immune system ramping up to fight the infection. Bacterial, viral, or fungal infections cause pneumonia.

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents Vaccines Hospitals Immunization 52

The Checkup by Singlecare

MAY 8, 2025

The goal is to calm down an overactive immune response and help relieve symptoms like swelling, pain, or trouble breathing. The exact definition of low dose can vary based on the individuals condition and the specific treatment plan prescribed by the healthcare provider, Dr. Ambardjieva says. But as with anything, it depends.

Immunization 59

Immunization Dosage Labelling Vaccines 59

The Thyroid Pharmacist

NOVEMBER 8, 2024

It is a comprehensive stool-based test that addresses a wide range of microbial targets (bacteria, opportunistic organisms, viruses, parasites, fungi, and normal flora), as well as immune and digestive markers. This can allow the body’s immune system to attack the thyroid (or elsewhere) versus the infection. [17]

Immunization 80

Immunization Adverse Reactions Hospitals Vaccines 80

The FDA Law Blog

NOVEMBER 18, 2024

Referencing an interview with Kennedy from 2023, the Post says that his views on health “were a head-scratching spaghetti of what we can only call warped conspiracy theories, and not just on vaccines.” He has equated vaccination to the Holocaust and argued that COVID-19 was “ethnically targeted” to spare Ashkenazi Jews and the Chinese.

FDA 116

FDA Vaccines Immunization 116